The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last decade. The immense data load published on its dual role in both tumorigenesis and inhibition of tumor growth and metastatic spread has transformed the cannabinoid receptors CB1 (CB1R) and CB2 (CB2R), and other...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Estefanía Moreno, Milena Cavic, Ana Krivokuca, Vicent Casadó, Enric Canela
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2019-04-01
Saila:	Frontiers in Pharmacology
Gaiak:	endocannabinoids G protein-coupled receptor cannabinoid CB1 receptor cannabinoid CB2 receptor ethical issues marijuana legalization
Sarrera elektronikoa:	https://www.frontiersin.org/article/10.3389/fphar.2019.00339/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!